Immunomedics, Inc. (IMMU) Trumps Q2 EPS, Revenue Views
IMMU Hot Sheet
Financial Fact:Total costs and expenses: 8.58M
Today's EPS Names:
TARO, BRLI, TLB, More
Immunomedics, Inc. (NASDAQ: IMMU) reported Q2 EPS of $0.27, $0.35 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $29.7 million versus the consensus estimate of $11.47 million.
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Immunomedics, Inc. (IMMU) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Stein Mart (SMRT) Reports Q1 Adj-EPS of 32c, Beats by 2c
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
